Bayer shares surged on Monday after the company reported encouraging late-stage clinical trial results for its experimental cardiovascular drug asundexian, offering a…
Latest Business News
-
-
Google Cloud has confirmed a new multi-million dollar contract with the NATO Communication and Information Agency to deliver a sovereign cloud environment…
-
This sharp contraction in overseas shipments has been attributed by industry officials and analysts primarily to the implementation of new trade measures…
-
Saudi Aramco is exploring a sweeping round of asset sales that could reshape how the company manages its vast energy and infrastructure…
-
On Monday, investors urged BHP to drop its pursuit of Anglo American and instead focus on its established growth strategy. This advice…
-
Stock
Interview: Social media made you the product, SocialFi makes you the owner, explains Zerion CEO Evgeny Yurtaev
by adminThe internet is having an identity crisis. Recent infrastructure collapses, from the AWS outage that knocked Snapchat offline to Snapchat’s sudden pivot…
-
Stock
Novo Nordisk shares plunge as oral semaglutide Alzheimer’s trial fails to show clinical benefit
by adminShares of Novo Nordisk fell sharply on Monday after the company announced that a high-profile trial testing whether its oral semaglutide medicine…
-
The S&P 500 Index was highly volatile last week as market participants reacted to key statements from Federal Reserve officials, the closely-watched…
